| Structure | Chemical Name | CAS | MF |
|
2-AMINO-2-(4-(TRIFLUOROMETHYL)PHENYL)ETHANOL HCl
|
1423032-18-1
|
C9H11ClF3NO
|
|
6-Methyl-imidazo[1,2-a]pyridine-3-carbonitrile
|
1423032-21-6
|
C9H7N3
|
|
2-cyclopropyl-N-methylethanamine hydrochloride
|
1423032-42-1
|
C6H14ClN
|
|
6-Fluoro-2-azaspiro[3.3]heptane HCl
|
1423032-55-6
|
C6H11ClFN
|
|
6,6-Difluorospiro[3.3]heptan-2-amine hydrochloride
|
1423032-71-6
|
C7H12ClF2N
|
|
2-(1-aminoethyl)aniline hydrochloride
|
1423032-93-2
|
C8H13ClN2
|
|
1-(5-ethyl-1H-1,2,4-triazol-3-yl)ethan-1-amine hydrochloride
|
1423033-12-8
|
C6H13ClN4
|
|
1-(2,6-dichlorophenyl)propan-2-amine hydrochloride
|
1423033-17-3
|
C9H12Cl3N
|
|
8-aMinochroMan-4-ol
|
1423033-30-0
|
C9H11NO2
|
|
3-(morpholin-2-yl)benzonitrile hydrochloride
|
1423033-37-7
|
C11H13ClN2O
|
|
tert-butyl4-hydroxy-4-(methoxymethyl)piperidine-1-carboxylate(WXC07869)
|
1423033-50-4
|
C12H23NO4
|
|
imidazo[1,2-a]pyridine-3-carboxylicacid
|
1423033-64-0
|
C8H6N2O2
|
|
1-amino-3,3-difluorocyclobutane-1-carboxylic acid hydrochloride
|
1423033-66-2
|
C5H8ClF2NO2
|
|
4-bromo-2-(methylsulfonyl)-1-nitrobenzene
|
1423033-81-1
|
C7H6BrNO4S
|
|
5-(2,5-difluorophenyl)pyrrolidin-3-ol hydrochloride
|
1423033-97-9
|
C10H12ClF2NO
|
|
3-Methyloxolan-3-amine hydrochloride
|
1423034-45-0
|
C5H12ClNO
|
|
3-Amino-1,6-dimethyl-1,2-dihydropyridin-2-one
|
1423034-54-1
|
C7H10N2O
|
|
5-(4-fluorophenyl)pyrrolidin-3-ol hydrochloride
|
1423034-84-7
|
C10H13ClFNO
|
|
Octyl-β-D-glucuronide methyl ester
|
1423035-40-8
|
C15H28O7
|
|
L-Arabinopyranose, 2,3,4-tris-O-(phenylmethyl)-
|
1423035-43-1
|
C26H28O5
|
|
7-BroMo-1-Methyl-1,2,3-benzotriazole-5-carbonitrile
|
1423037-16-4
|
C8H5BrN4
|
|
3-[4-(HydroxyMethyl)phenyl]pyridine-2-carbonitrile
|
1423037-18-6
|
C13H10N2O
|
|
4-BroMo-2-ethoxy-5-fluorobenzonitrile
|
1423037-19-7
|
C9H7BrFNO
|
|
2-Methanesulfonyl-5-nitrobenzaldehyde
|
1423037-20-0
|
C8H7NO5S
|
|
N-(4-Pyrrolidinobenzyl) 4-pyrrolidinobenzaMide
|
1423037-21-1
|
C22H27N3O
|
|
Methyl 7-broMo-1-ethyl-1,3-benzodiazole-5-carboxylate
|
1423037-23-3
|
C11H11BrN2O2
|
|
Methyl 4-aMino-3-(isopropylaMino)benzoate
|
1423037-24-4
|
C11H16N2O2
|
|
2-(2-Isopropylpyrazol-3-yl)-3-Methylpyridine
|
1423037-25-5
|
C12H15N3
|
|
3-broMo-5-chloro-6-Methylpyridin-2-ol
|
1423037-27-7
|
C6H5BrClNO
|
|
Methyl 7-broMo-1-ethyl-2-Methyl-1,3-benzodiazole-5-carboxylate
|
1423037-29-9
|
C12H13BrN2O2
|
|
Ethyl 7-broMo-1-Methyl-1,2,3-benzotriazole-5-carboxylate
|
1423037-30-2
|
C10H10BrN3O2
|
|
Methyl 4-aMino-3-(tert-butylaMino)benzoate
|
1423037-31-3
|
C12H18N2O2
|
|
N-Cyclopentyl L-Z-Isoleucinamide
|
1423037-32-4
|
C19H28N2O3
|
|
5-ForMyl-N,N-diMethyl-3-(trifluoroMethyl)pyrazole-1-sulfonaMide
|
1423037-33-5
|
C7H8F3N3O3S
|
|
2-Ethoxy-1-Methanesulfonyl-4-nitrobenzene
|
1423037-34-6
|
C9H11NO5S
|
|
7-BroMo-1H-1,2,3-benzotriazole-5-carbonitrile
|
1423037-37-9
|
C7H3BrN4
|
|
4-BroMo-2-ethoxy-1-Methanesulfonylbenzene
|
1423037-38-0
|
C9H11BrO3S
|
|
Ethyl 7-broMo-1-Methyl-1,3-benzodiazole-5-carboxylate
|
1423037-39-1
|
C11H11BrN2O2
|
|
Methyl 1-BOC-4-(2-ethoxy-2-oxoethyl)piperidine-4-carboxylate
|
1423037-40-4
|
C16H27NO6
|
|
Ethyl 3,4-diaMino-5-broMobenzoate
|
1423037-41-5
|
C9H11BrN2O2
|
|
N-(3-Methoxypropyl) L-Z-isoleucinamide
|
1423037-42-6
|
C18H28N2O4
|
|
(±)-trans-4-(4-methyl-phenyl)-pyrrolidine-3-carboxylic acidHCl (Rel)
|
1423037-43-7
|
C12H15NO2.ClH
|
|
N-Isopropyl L-Z-isoleucinamide
|
1423037-44-8
|
C17H26N2O3
|
|
Ethyl 3-aMino-5-broMo-4-(MethylaMino)benzoate
|
1423037-45-9
|
C10H13BrN2O2
|
|
Ethyl 3-broMo-4-(MethylaMino)-5-nitrobenzoate
|
1423037-47-1
|
C10H11BrN2O4
|
|
(trans)-4-(3-Bromo-phenyl)-pyrrolidine-3-carboxylic acid-HCl
|
1423037-48-2
|
C11H13BrClNO2
|
|
(4-formyl-1H-[1,2,3]-triazol-1-yl)methyl pivalate
|
1423037-50-6
|
C9H13N3O3
|
|
N-Propyl L-Z-isoleucinamide
|
1423037-51-7
|
C17H26N2O3
|
|
7-BroMo-1-butyl-2-Methyl-1,3-benzodiazole-5-carbonitrile
|
1423037-54-0
|
C13H14BrN3
|
|
N-Cyclopentyl L-Z-ValinaMide
|
1423037-55-1
|
C18H26N2O3
|
|
N-Butyl L-Z-isoleucinamide
|
1423037-56-2
|
C18H28N2O3
|
|
1,3-Bis[5-broMo-2-(trifluoroMethyl)phenyl]triaz-1-ene
|
1423040-58-7
|
C14H7Br2F6N3
|
|
(R)-7-Methoxy-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride
|
1423040-65-6
|
C11H16ClNO
|
|
(1S)-1-(5-Chloro-2-fluorophenyl)ethan-1-amine hydrochloride
|
1423040-76-9
|
C8H10Cl2FN
|
|
(1S)-7-(propan-2-yloxy)-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride
|
1423040-91-8
|
C13H20ClNO
|
|
Poly[(9,9-dioctylfluorenyl-2,7-diyl)-alt-(6,6'-{2,2'- bipyridine})]
|
1423043-97-3
|
|
|
2-(azetidin-3-yl)acetonitrile hydrochloride
|
1423057-36-6
|
C5H9ClN2
|
|
BRD9757
|
1423058-85-8
|
C6H9NO2
|
|
Regadenoson Impurity 3
|
1423073-21-5
|
C15H17N7O6
|
|
RTC-5
|
1423077-49-9
|
C24H22ClF3N2O3S
|
|
(R)-N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-2-hydroxypropyl)-4-(trifluoromethoxy)benzenesulfonamide
|
1423077-95-5
|
C24H23F3N2O4S
|
|
3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-b]pyridazine
|
1423078-56-1
|
C12H16BN3O2
|
|
(3R,4S)-4-p-tolylpyrrolidine-3-carboxylic acid
|
1423117-69-4
|
C12H15NO2
|
|
Dabrafenib-D9
|
1423119-98-5
|
C23H20F3N5O2S2
|
|
5-chloro-6-nitro-1H-indole
|
1423120-30-2
|
C8H5ClN2O2
|
|
6-Chloroindole-5-carbonitrile
|
1423120-66-4
|
C9H5ClN2
|
|
1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-1,2,3-triazole
|
1423123-94-7
|
C9H16BN3O2
|
|
3-AMino-5-(cyclopropylcarbaMoyl)phenylboronic acid
|
1423129-20-7
|
C10H13BN2O3
|
|
RN983
|
1423129-83-2
|
C34H37FN8O3
|
|
Methyl 3-(Boc-aMino)-3-(3-hydroxyphenyl)propanoate
|
1423134-61-5
|
C15H21NO5
|
|
DPP610-Br
|
1423138-95-7
|
C46H71BrN2O2S2
|
|
N,N-dimethyl-2-[2-(2-propen-1-yloxy)ethoxy]-Ethanamine
|
1423140-76-4
|
C9H19NO2
|
|
Fasudil IMpurity 1
|
1423155-03-6
|
C14H17N3O2S
|
|
3-Bromo-1-methyl-1H-indole-6-sulfonyl chloride
|
1423161-84-5
|
C9H7BrClNO2S
|
|
Ad-BellGiphos-1-Nap
|
1423165-22-3
|
C31H37OP
|
|
RIP2 kinase inhibitor 1
|
1423186-80-4
|
C21H22N4O4S2
|
|
7-Chloro-6-iodo-1H-quinazolin-4-one
|
1423187-59-0
|
C8H4ClIN2O
|
|
Pep2m, myristoylated
|
1423381-07-0
|
C63H118N18O14S
|
|
Benzenepropanoic acid, 4-bromo-α-[1-(methylamino)ethylidene]-β-oxo-, methyl ester
|
1423699-80-2
|
C13H14BrNO3
|
|
5-iodo-3-methylisothiazole-4-carboxamide
|
1423700-20-2
|
C5H5IN2OS
|
|
methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-indene-1-carboxylate
|
1423700-47-3
|
C17H23BO4
|
|
1-[4-(4.4.5.5-tetramethyl-[1.3.2]dioxaborolan-2-yl)-biphenyl-4-yl]-cyclopropanecarboxylic acid methyl ester
|
1423700-75-7
|
C23H27BO4
|
|
ethyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)tetrahydro-2H-pyran-4-carboxylate
|
1423702-59-3
|
C20H29BO5
|
|
methyl 1-(6-bromonaphthalen-2-yl)cyclopropane-1-carboxylate
|
1423703-16-5
|
C15H13BrO2
|
|
methyl 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutane-1-carboxylate
|
1423704-86-2
|
C18H25BO4
|
|
methyl 1-ethynylcyclopropanecarboxylate
|
1423705-50-3
|
C7H8O2
|
|
1-(4-Bromophenyl)-1H-imidazole-5-carboxylic acid
|
1423706-23-3
|
C10H7BrN2O2
|
|
methyl 1-[2-chloro-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropane-1-carboxylate
|
1423706-80-2
|
C17H22BClO4
|
|
methyl 1-(thieno[3,2-B]thiophen-2-yl)cyclopropane-1-carboxylate
|
1423707-57-6
|
C11H10O2S2
|
|
SP2509
|
1423715-09-6
|
C19H20ClN3O5S
|
|
Seclidemstat
|
1423715-37-0
|
C20H23ClN4O4S
|
|
6,6-Dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid ethyl ester
|
1423716-54-4
|
C12H18N2O2
|
|
5,5-Dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid ethyl ester
|
1423716-55-5
|
C12H18N2O2
|
|
Nerandomilast
|
1423719-30-5
|
C20H26ClN6O2S-
|
|
L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[(6-fluoro-3-pyridinyl)carbonyl]amino]pentyl]amino]carbonyl]-
|
1423758-00-2
|
C18H23FN4O8
|
|
(4-Fluorobenzofuran-2-yl)boronic acid
|
1423791-86-9
|
C8H6BFO3
|
|
Apixaban Impurity 17
|
1423803-24-0
|
C20H19N5O3
|
|
7α-Hydroxy-4,11-cadinadiene-3,8-dione
|
1423809-64-6
|
C15H20O3
|
|
2H-Tetrazole, 5-[4-(1H-1,2,4-triazol-1-yl)phenyl]-
|
1423810-54-1
|
C9H7N7
|
|
Tat-Beclin 1 Peptide
|
1423821-88-8
|
|